Alshaygy Ibrahim, Alageel Musab, Alaseem Abdulrahman, Alogayyel Motaz, Griffin Anthony, Shaheen Mahmoud, Alsudairi Abdulaziz, Murrad Khalid, Alqahtani Sarah, Alqahtani Rana, Alawami Furqan, Algarni Nizar, Albishi Waleed, Aljassir Fawzi
Department of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Musculoskeletal Oncology Unit, Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Canada.
J Orthop Surg Res. 2025 Jul 28;20(1):715. doi: 10.1186/s13018-025-05980-0.
The treatment of musculoskeletal (MSK) tumors involving the extremities has evolved over the past decade with the introduction of prosthesis and new chemotherapy regimen. The Toronto Extremity Salvage Score system (TESS) is a patient-filled questionnaire that measures the functional status of patients with MSK tumors who underwent limb-salvaging procedure. The purpose of this study is to translate TESS into Arabic (TESS-AR) and to examine its reliability and validity.
Our study is a multi-center in Riyadh, Saudi Arabia. Arabic-speaking adults diagnosed with MSK tumors involving the extremities were included. TESS-AR was created following clear, user-friendly guidelines for translation. Moreover, reliability and validity were measured using the test-retest method and construct validity, respectively.
108 participants completed the TESS-AR, 56% had lower limb tumors. The participants reported that the TESS-AR was clear and all questions and answers were understood. The test-retest reliability showed excellent reliability, with an interclass correlation coefficient of 0.965 for both the lower and upper extremity TESS-AR. Cronbach's alpha of lower extremity TESS-AR was 0.972, whereas that of upper extremity TESS-AR was 0.969, indicating strong internal consistency. The construct validity between TESS-AR and SF-36 showed a strong and moderated correlation between most of the components, with a Pearson correlation coefficient >0.40. Similar results were found between TESS-AR and EORTC QLQ C30.
The TESS-AR is a comprehensible, valid, and reliable score for assessing functional outcomes in patients with extremity tumors. We believe that TESS-AR can be used by clinicians, researchers, and patients alike.
在过去十年中，随着假体的引入和新化疗方案的出现，涉及四肢的肌肉骨骼（MSK）肿瘤的治疗方法不断发展。多伦多肢体挽救评分系统（TESS）是一份由患者填写的问卷，用于衡量接受保肢手术的MSK肿瘤患者的功能状态。本研究的目的是将TESS翻译成阿拉伯语（TESS-AR），并检验其信度和效度。
我们的研究是在沙特阿拉伯利雅得进行的多中心研究。纳入了被诊断为患有涉及四肢的MSK肿瘤的讲阿拉伯语的成年人。TESS-AR是按照清晰、用户友好的翻译指南创建的。此外，分别使用重测法和结构效度来测量信度和效度。
108名参与者完成了TESS-AR，56%的人患有下肢肿瘤。参与者报告说TESS-AR清晰易懂，所有问题和答案都能理解。重测信度显示出极佳的信度，下肢和上肢TESS-AR的组内相关系数均为0.965。下肢TESS-AR的Cronbach's alpha为0.972，而上肢TESS-AR的Cronbach's alpha为0.969，表明内部一致性很强。TESS-AR与SF-36之间的结构效度显示，大多数成分之间存在强且适度的相关性，Pearson相关系数>0.40。在TESS-AR与欧洲癌症研究与治疗组织QLQ C30之间也发现了类似的结果。
TESS-AR是一种用于评估四肢肿瘤患者功能结局的可理解、有效且可靠的评分系统。我们相信临床医生、研究人员和患者都可以使用TESS-AR。
